Medical Devices Startups

AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.

1 investor

Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions. The company operates an ISO 13485 certified manufacturing facility in Ireland and was acquired by Haemonetics Corporation in January 2026.

1 investor

VIVEbiotech is a contract development and manufacturing organization (CDMO) specialized exclusively in lentiviral vectors for both ex vivo and in vivo administration, following EMA and FDA regulatory requirements. It serves biotech and pharmaceutical companies across the US, Europe, Asia, and Australia.

1 investor

Vivoryon is a biotech company focused on developing therapeutics, with a leadership team experienced in pharmaceutical development, clinical research, and life sciences business operations.

1 investor

VivoSensMedical develops sensor-based medical devices for personalized diagnostics using core body temperature as a biomarker, with initial focus on women's health and cycle diagnostics. The company translates continuous physiological data into specialized diagnostic solutions for reproductive medicine, autoimmune disease, and circadian rhythm disorders.

1 investor

Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines. It operates in the biotech/therapeutics space, working on drug development and related laboratory research.

1 investor

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.

1 investor

Voler Systems publishes a podcast featuring conversations with industry leaders about engineering innovation, product development, and technologies for next-generation devices.

1 investor

Volpixl develops AI-driven technologies to improve medical imaging workflows by enhancing data quality, reducing processing complexity, and enabling faster visualization for healthcare providers.

1 investor

Volt Health manufactures a wearable electrostimulation device designed to treat incontinence and other conditions by stimulating muscles and providing feedback to affected receptors. The device targets conditions including incontinence and migraines using proprietary technology.

1 investor

Volumina Medical develops advanced biomaterial technologies for soft-tissue regeneration and restoration. The company translates scientific discoveries from material science and engineering into minimally invasive medical solutions for clinical use.

1 investor

Voodoo Manufacturing operates a high-volume 3D printing factory producing plastic parts at scale, alongside offering 3D design services including CAD design to convert concepts into manufacturable files. The company serves manufacturers, designers, and businesses of all sizes needing digital manufacturing from prototyping to production.

1 investor

Voro Therapeutics develops tumor-activated biologics, specifically an antibody-based platform called PrimeBody™, designed to treat cancers including colorectal, gastric, prostate, and lung cancers while minimizing systemic toxicity. The company leverages masking technology and conditionally activated linkers to enable systemic delivery with tumor-specific activation.

1 investor

Vortex Surgical is a medical device company. The page lists its home office leadership team but does not describe the company's specific products or services.

1 investor

Voyage Biomedical develops cooling technology designed to reduce brain injury in stroke patients.

1 investor

Voythos develops precision medicine tools for vascular surgeons, including predictive intelligence software for aortic disease surveillance and real-time surgical coding assistance. The company is building AI models trained on large longitudinal patient datasets to improve clinical outcomes in vascular disease management.

1 investor

VPCIR develops non-invasive lateral flow diagnostic test sticks that detect living pathogens in saliva, using patented Rolling Circle Amplification technology for point-of-care Tuberculosis testing. Its pipeline extends to other infectious diseases such as Malaria, targeting affordable, accessible diagnostics for global healthcare.

1 investor

VR Life develops VR Vitalis, a certified medical device and virtual reality application used for physical, neurological, and cognitive rehabilitation as well as client activation in healthcare, social care, and workplace settings. Based in Ostrava, Czech Republic, it serves rehabilitation departments, hospitals, senior care homes, and employers, combining traditional rehabilitation methods with immersive VR and game elements.

1 investor

VS3 Medical is a medical device company developing the VS3 Medical Stent System, an investigational neurovascular implant designed to treat symptomatic venous sinus stenosis within the dural venous sinus anatomy. The device is not yet available for sale and is undergoing first-in-human clinical study.

1 investor

VUNO develops AI-based medical software for healthcare professionals, including an early warning system that predicts in-hospital cardiac arrest and patient deterioration among inpatients in general wards. The company's tools use vital signs and clinical data to assess risk and support earlier intervention.

1 investor

VUZE Medical develops computer-guided surgical systems for minimally-invasive spine procedures using real-time image registration. The company targets orthopedic surgeons performing thoracolumbar fixation, augmentation, and pain therapy interventions.

1 investor

vVARDIS develops biomimetic, non-invasive dental products based on P11-4 peptide technology to treat early-stage tooth decay by regenerating enamel without drilling. The Swiss company sells chairside solutions to dental professionals, DSOs, and universities.

1 investor

WAHTS develops wireless, boothless hearing testing systems for hearing health access and hearing conservation programs.

1 investor

Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients. The company is a biotech focused on therapeutic development.

1 investor